Market niche Established IONM provider for spine and cranial surgeries with active expansion goals across hospitals, presenting opportunities to upsell expanded monitoring services, additional procedures, and longer-term contracts with perioperative teams.

Growth potential Current footprint covers 14 hospitals and 29 surgeons; target hospitals with similar surgical volumes or new facility openings may be receptive to STS’s focused neurophysiology monitoring capabilities and rapid-onboard talent.

Technology edge STS emphasizes cutting-edge instrumentation and modalities; sales conversations can highlight compatibility with client tech stacks and potential for adopting advanced intraoperative monitoring modalities to differentiate from competitors.

Strategic partners Small team size (2-10 employees) suggests potential for scalable partnerships, remote monitoring options, or hybrid service models with existing hospital IONM staff to extend coverage and reduce patient risk.

Financial signal Revenue range indicates a growing but mid-market player; position STS as a cost-effective, high-quality IONM partner capable of expanding to additional procedures, hospitals, and surgeon networks to drive incremental revenue.